Clinical Trial Update: A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in Healthy Participants [Phase 1]

View source ↗

Summary

AL-034 underwent a Phase 1 trial in healthy participants to assess safety, tolerability, and pharmacokinetics, with Hepatitis B listed as the associated conditi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• AL-034

Snippet

Sponsor: Alios Biopharma Inc. | Conditions: Hepatitis B | Phase 1 | Status: COMPLETED